|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 37.89 EUR | -2.75% |
|
+4.28% | +0.08% |
BERLIN (Reuters) - Kidney dialysis provider Fresenius Medical Care (FMC) on Sunday revised down its forecast for 2022, expecting net income to decline this year, dragged down by rising labour costs and a slower than expected recovery in North America business.
The company now expects net income to decline in the high-teens to mid-20s percentage range this year, down from its previous outlook of a high-teens percentage drop. It still expects revenue to grow at a low single digit percentage rate.
FMC said net income dropped 16% in third quarter to 230 million euros ($229.15 million) while operating income fell by 7% to 472 million euros in the quarter.
($1 = 1.0037 euros)
(Reporting by Riham Alkousaa; Editing by Alison Williams)
| 1st Jan change | Capi. | |
|---|---|---|
| +0.08% | 12.22B | |
| -14.84% | 85.42B | |
| +16.38% | 84.38B | |
| +10.92% | 29.39B | |
| -12.54% | 17.49B | |
| -2.89% | 16.44B | |
| -1.69% | 15.28B | |
| -31.23% | 11.98B | |
| -3.29% | 11.71B | |
| +25.90% | 11.64B |
FRESENIUS MEDICAL CARE AG 
